Latisse

Eyelash, Glaucoma, Open Angle Glaucoma + 1 more

Treatment

1 FDA approval

18 Active Studies for Latisse

What is Latisse

Bimatoprost

The Generic name of this drug

Treatment Summary

Bimatoprost, also known as Latisse or Lumigan, is a drug used to treat ocular hypertension, glaucoma, and sparse eyelash growth. It belongs to a class of drugs called prostamides, which are synthetic versions of natural prostaglandin. Bimatoprost is available in an ophthalmic solution and implant form. It was approved by the FDA in 2001 for ocular hypertension and 2008 for sparse eyelash growth, as it was found to be an unexpected side effect of the drug.

Lumigan

is the brand name

image of different drug pills on a surface

Latisse Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Lumigan

Bimatoprost

2001

25

Approved as Treatment by the FDA

Bimatoprost, otherwise called Lumigan, is approved by the FDA for 1 uses like Eyelash .

Eyelash

Effectiveness

How Latisse Affects Patients

High pressure in the eye can lead to vision loss from glaucoma. Bimatoprost is used to lower this pressure and reduce the risk of vision loss. However, it may also cause changes in the color of the eyelid, iris, or eyelashes. This can be especially noticeable if only one eye is treated. Patients should be aware of these potential side effects before taking bimatoprost.

How Latisse works in the body

Bimatoprost works in the eyes to reduce pressure and prevent damage to the optic nerve. It does this by mimicking the effects of a natural molecule called prostaglandin F2α. This causes an increase in the flow of fluid in the eye, which reduces pressure and lowers the risk of optic nerve damage. Bimatoprost does not affect the production of fluid within the eye, only the outflow.

When to interrupt dosage

The suggested dose of Latisse is contingent upon the diagnosed condition, including Open Angle Glaucoma, Increased Intra Ocular Pressure (IOP) and Eyelash. The measure of dosage changes as per the technique of delivery outlined in the table underneath.

Condition

Dosage

Administration

Ocular Hypertension

, 0.3 mg/mL, 0.1 mg/mL, 0.03 %, 0.01 %, 0.003 mg/mL, 0.01 mg

, Solution / drops, Solution / drops - Ophthalmic, Ophthalmic, Solution, Solution - Ophthalmic, Solution - Topical, Topical, Implant

Eyelash

, 0.3 mg/mL, 0.1 mg/mL, 0.03 %, 0.01 %, 0.003 mg/mL, 0.01 mg

, Solution / drops, Solution / drops - Ophthalmic, Ophthalmic, Solution, Solution - Ophthalmic, Solution - Topical, Topical, Implant

Glaucoma

, 0.3 mg/mL, 0.1 mg/mL, 0.03 %, 0.01 %, 0.003 mg/mL, 0.01 mg

, Solution / drops, Solution / drops - Ophthalmic, Ophthalmic, Solution, Solution - Ophthalmic, Solution - Topical, Topical, Implant

Open Angle Glaucoma

, 0.3 mg/mL, 0.1 mg/mL, 0.03 %, 0.01 %, 0.003 mg/mL, 0.01 mg

, Solution / drops, Solution / drops - Ophthalmic, Ophthalmic, Solution, Solution - Ophthalmic, Solution - Topical, Topical, Implant

Warnings

There are 20 known major drug interactions with Latisse.

Common Latisse Drug Interactions

Drug Name

Risk Level

Description

Acebutolol

Minor

Bimatoprost may increase the hypotensive activities of Acebutolol.

Aliskiren

Minor

Bimatoprost may increase the hypotensive activities of Aliskiren.

Ambrisentan

Minor

Bimatoprost may increase the hypotensive activities of Ambrisentan.

Angiotensin 1-7

Minor

Bimatoprost may increase the hypotensive activities of Angiotensin 1-7.

Azilsartan medoxomil

Minor

Bimatoprost may increase the hypotensive activities of Azilsartan medoxomil.

Latisse Toxicity & Overdose Risk

There is currently no information on what to do in the event of a bimatoprost overdose. If an overdose occurs, supportive care should be provided.

image of a doctor in a lab doing drug, clinical research

Latisse Novel Uses: Which Conditions Have a Clinical Trial Featuring Latisse?

34 active clinical trials are presently assessing the potential of Latisse for treating Ocular Hypertension, Elevated Intra Ocular Pressure (IOP) and Eyelash Enhancement.

Condition

Clinical Trials

Trial Phases

Open Angle Glaucoma

10 Actively Recruiting

Phase 3, Not Applicable, Phase 4

Glaucoma

0 Actively Recruiting

Eyelash

0 Actively Recruiting

Ocular Hypertension

10 Actively Recruiting

Phase 3, Phase 1, Phase 2, Not Applicable, Phase 4

Latisse Reviews: What are patients saying about Latisse?

5

Patient Review

11/27/2016

Latisse for Increased Number of Eyelashes

I noticed a difference in my lash length after only one week of using this product! I've been using it for almost a month now, and my lashes are darker, longer, and fuller. The only downside is that the brushes that come with it don't seem to work very well.

5

Patient Review

1/13/2017

Latisse for Increased Number of Eyelashes

I've been using Latisse for a while now, and it's definitely worth it. My eyelashes were practically nonexistent before I started using this product, but now they're thick and full. I would recommend stretching out the number of uses by putting the drops into the top of the bottle and dipping the applicator in before each use; that way you get more bang for your buck!

5

Patient Review

5/27/2022

Latisse for Increased Number of Eyelashes

I've been using Nulastin for 2.5 months and I'm really happy with the results. My lashes are longer, thicker, and darker. I tried Latisse for one year, but it was a waste of money compared to this product.

4

Patient Review

4/26/2017

Latisse for Increased Number of Eyelashes

I've been using this treatment for a year with great results. The only downside is the cost, but I've found ways to make it last longer.

3.7

Patient Review

6/11/2017

Latisse for Reduced Eyelash Growth

I was really disappointed when they changed the brushes. The new ones are less refined, thicker, and you need a knife or scissors to open them!

3.3

Patient Review

9/30/2017

Latisse for Increased Number of Eyelashes

I've been using Latisse for three months and have seen a significant growth in my eyelashes. However, they haven't thickened or darkened as I'd hoped. Additionally, I've experienced more than the occasional burning and itching sensation; enough that I'm considering discontinuing use of this product.

3

Patient Review

5/29/2022

Latisse for Reduced Eyelash Growth

Latisse helped my eyes modestly. Listen up ladies - forget Latisse, the real trick to make your eyes look younger is Upneeq! That stuff is INSANE! I used Latisse for 1 year and nobody ever commented on my eyes. I used Upneeq just a few times and I swear they look so wide and bright. I told 3 girlfriends and they're also hooked. They call it a cup of coffee for their eyes. Bottom line: I'd much rather spend my hard earned money on Upneeq.

3

Patient Review

5/29/2022

Latisse for Reduced Eyelash Growth

Latisse helped my eyes a little bit, but it was nothing compared to Upneeq. The latter made my eyes look so wide and bright that I had multiple people compliment me on them. It's definitely worth the money in my opinion.

2.3

Patient Review

8/5/2022

Latisse for Reduced Eyelash Growth

Though this product is effective, the ingredients are unfortunately not good for you. I started experiencing symptoms like drooping eyelids and itchiness six months after using it. Do not recommend.

2.3

Patient Review

8/2/2017

Latisse for Reduced Eyelash Growth

Not only did this not work as intended, it actually had the opposite effect in some ways. My eyelids turned red and my lashes neither lengthened nor thickened. I used it daily for 3 years; very frustrating and big waste of money.

2.3

Patient Review

6/15/2017

Latisse for Increased Number of Eyelashes

My eye lashes have fallen out and I've experienced breakage since using this product. I contacted the company but haven't received a response back yet.

2

Patient Review

1/11/2017

Latisse for Increased Number of Eyelashes

I saw significant results with Latisse at first, but they stopped after about two years of use. I kept using it in the hopes that my lashes would go back to normal, but there was only ever a very small improvement. It's not worth the money or the irritation.

2

Patient Review

5/27/2022

Latisse for Increased Number of Eyelashes

I used Latisse for an entire year as directed, and saw zero lash growth. Such a disappointment and waste of money.

1

Patient Review

8/31/2022

Latisse for Reduced Eyelash Growth

Unfortunately, I had an allergic reaction to this product that resulted in my eyelids turning purple. I would not recommend it.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about latisse

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How long does it take for Latisse to work?

"It takes at least two months for the lashes to begin to thicken, and full results occur within three to four months. You must use Latisse nightly to see full results. If you stop using Latisse, your eyelashes will eventually return to their previous thickness."

Answered by AI

How much does Latisse cost per month?

"Latisse is a cheaper and more effective alternative to eyelash extensions, costing around $110 per month. It offers several advantages over extensions, including being more affordable and effective."

Answered by AI

Does Latisse work permanently?

"The effects of Latisse are not permanent and will only last as long as the patient continues to use the product. The maximum effects will be seen after 16 weeks of use."

Answered by AI

What happens when you stop using Latisse?

"If you stop using Latisse, your eyelashes will gradually return to their previous appearance, which can take anywhere from a few weeks to several months or more."

Answered by AI

Can I buy Latisse over the counter?

"Latisse is a prescription medication in the United States and is not available over the counter. In most cases, one cannot simply buy Latisse online. The first step is getting a Latisse prescription from a medical provider before a pharmacy will dispense it."

Answered by AI

What are the risks of Latisse?

"These include skin darkening, eye irritation, dryness of the eyes, and redness of the eyelids.

The most common side effects of using LATISSE are itching and redness in the eyes, which were reported by 4% of clinical trial patients. LATISSE solution may also cause less common side effects, including skin darkening, eye irritation, and dryness or redness of the eyelids, which usually occur near where LATISSE is applied."

Answered by AI

Clinical Trials for Latisse

Have you considered Latisse clinical trials?

We made a collection of clinical trials featuring Latisse, we think they might fit your search criteria.
Go to Trials

Have you considered Latisse clinical trials?

We made a collection of clinical trials featuring Latisse, we think they might fit your search criteria.
Go to Trials
Image of Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham in Birmingham, United States.

AI-Based Screening for Glaucoma

18+
All Sexes
Birmingham, AL

The goal of this clinical trial is to learn if implementation of an eye screening program at Federally Qualified Health Center (FQHC) clinics provides results that participants may have glaucoma, and/or other eye conditions (diabetic retinopathy, cataract, visual acuity impairment). The glaucoma screening will incorporate use of an artificial intelligence (AI)-assisted screening tool. This project is called AI-RONA. The main questions it aims to answer are: * How does this eye screening program compare to the rate of glaucoma and other eye conditions detected at other FQHC clinics where the screening program has not been implemented? * Do particpants who screen positive for these conditions adhere to the physician's recommendation for a follow-up examination by an optometrist or ophthalmologist? * Are referral rates for a follow-up comprehensive eye exam by an optometrist or ophthalmologist similar to those implemented by an ophthalmologist using telemedicine (that is, using the results of the screening to make a diagnosis remotely)? * What is the cost-effectiveness of the AI-assisted screening program in diagnosing glaucoma as compared to a physician-guided program? * Are participants completing the screening satisfied with it? * Are physicians at the FQHC clinics administering the screening satisfied with it? Participants will: * Undergo an ocular screening whose goal is to detect glaucoma, diabetic retinopathy, cataract, and/or impairment in visual acuity. If the screening indicates that participants may have these conditions, participants will be referred for a comprehensive eye examination by an optometrist or ophthalmologist. * Following the screening, participants and physicians will complete a survey on their satisfaction with the program.

Recruiting
Has No Placebo

Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham

Cynthia Owsley, PhD

Have you considered Latisse clinical trials?

We made a collection of clinical trials featuring Latisse, we think they might fit your search criteria.
Go to Trials